Here are four key points:
1. Zimmer Biomet anticipates full-year adjusted earnings per share of $7.90 to $8. This estimate surpasses the company's previous forecast of $7.85 to $8 per share.
2. The company expects 2016 revenue to hit between $7.68 billion and $7.72 billion.
3. Zimmer Biomet experienced a net loss of $31.3 million for the quarter ending June 30.
4. The company's second quarter earnings hit $2.02 per share, an increase from $1.58 for the same period a year prior.
More articles on devices:
Orthofix's PHOENIX MIS Fixation System receives regulatory clearance in Japan: 5 things to know
